Mark D. Parker
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Purpose: This research investigates the association between benzodiazepines (BZD) and cancer patient survival outcomes, the pancreatic cancer tumor microenvironment, and cancer-associated fibroblast (CAF) signaling. Experimental Design: Multivariate Cox regression modeling was used to retrospectively measure associations between Roswell Park cancer patient survival outcomes and BZD prescription records. IHC, H&E, Masson's trichrome, RNAscope, and RNA sequencing were used to evaluate the impact of lorazepam (LOR) on the murine PDAC tumor microenvironment. ELISA and qPCR were used to determine the impact of BZDs on IL6 expression or secretion by human-immortalized pancreatic CAFs. PRESTO-Tango assays, reanalysis of PDAC single-cell sequencing/TCGA data sets, and GPR68 CRISPRi knockdown CAFs were used to determine the impact of BZDs on GPR68 signaling. Results: LOR is associated with worse progression-free survival (PFS), whereas alprazolam (ALP) is associated with improved PFS, in pancreatic cancer patients receiving chemotherapy. LOR promotes desmoplasia (fibrosis and extracellular matrix protein deposition), inflammatory signaling, and ischemic necrosis. GPR68 is preferentially expressed on human PDAC CAFs, and n-unsubstituted BZDs, such as LOR, significantly increase IL6 expression and secretion in CAFs in a pH and GPR68-dependent manner. Conversely, ALP and other GPR68 n-substituted BZDs decrease IL6 in human CAFs in a pH and GPR68-independent manner. Across many cancer types, LOR is associated with worse survival outcomes relative to ALP and patients not receiving BZDs. Conclusions: We demonstrate that LOR stimulates fibrosis and inflammatory signaling, promotes desmoplasia and ischemic necrosis, and is associated with decreased pancreatic cancer patient survival.
Year:
2025
Mutations in the H + (OH − ) conductor SLC4A11 result in corneal endothelial dystrophy. In previous studies using mouse Slc4a11, we showed that the pK value that governs the intracellular pH dependence of SLC4A11 (pK i ) is influenced by extracellular pH (pH e ). We also showed that some mutations result in acidic or alkaline shifts in pK i , indicating that the pH dependence of SLC4A11 is important for physiological function. An R125H mutant, located in the cytosolic amino terminus of SLC4A11, apparently causes a complete loss of function, yet the anion transport inhibitor 4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid (DIDS) can partially rescue SLC4A11/R125H activity. In the present study we set out to determine whether the effect of R125H is explained by an extreme shift in pK i . In Xenopus oocytes, we measured SLC4A11-mediated H + (OH − ) conductance while monitoring pH i . We find that 1) the human corneal variant SLC4A11-B has a more acidic pK i than mouse Slc4a11, likely due to the presence of an NH 2 -terminal appendage; 2) pK i for human SLC4A11 is acid-shifted by raising pH e to 10.00; and 3) R125H and R804H mutants mediate substantial H + (OH − ) conductances at pH e = 10.00, with pK i shifted into the wild-type range. These data suggest that the defect in each is a shift in pK i at physiological pH e , brought about by a disconnection in the mechanisms by which pH e influences pK i . Using de novo modeling, we show that R125 is located at the cytosolic dimer interface and suggest that this interface is critical for relaying the influence of pH e on the external face of the transmembrane domain to the intracellular, pK i -determining regions.
Year:
2022
Collaborators (6)
Janusz Franco-Barraza
Assistant Research Professor
Fox Chase Cancer Center
Michael Feigin
Assistant Professor
Roswell Park Comprehensive Cancer Center
Abdulrahman Alahmari
Assistant professor
prince sattam bin abdulaziz university
Mukund Seshadri
Roswell Park Comprehensive Cancer Center
Christos Fountzilas
Associate Professor
Roswell Park Comprehensive Cancer Center
Nina Steele
Assistant Professor
University of Cincinnati
Make your next move.
Prepare your application
Review drafts before you send them.